100 related articles for article (PubMed ID: 28035011)
1. Invariant Natural Killer T Cells Are Pathogenic in the HLA-DR4-Transgenic Humanized Mouse Model of Toxic Shock Syndrome and Can Be Targeted to Reduce Morbidity.
Szabo PA; Rudak PT; Choi J; Xu SX; Schaub R; Singh B; McCormick JK; Haeryfar SMM
J Infect Dis; 2017 Mar; 215(5):824-829. PubMed ID: 28035011
[TBL] [Abstract][Full Text] [Related]
2. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
3. Swift Intrahepatic Accumulation of Granulocytic Myeloid-Derived Suppressor Cells in a Humanized Mouse Model of Toxic Shock Syndrome.
Szabo PA; Goswami A; Memarnejadian A; Mallett CL; Foster PJ; McCormick JK; Haeryfar SM
J Infect Dis; 2016 Jun; 213(12):1990-5. PubMed ID: 26908735
[TBL] [Abstract][Full Text] [Related]
4. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
5. Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist.
Walker KM; Rytelewski M; Mazzuca DM; Meilleur SA; Mannik LA; Yue D; Brintnell WC; Welch I; Cairns E; Haeryfar SM
Immunol Cell Biol; 2012 Jul; 90(6):630-9. PubMed ID: 21912419
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.
Hayworth JL; Kasper KJ; Leon-Ponte M; Herfst CA; Yue D; Brintnell WC; Mazzuca DM; Heinrichs DE; Cairns E; Madrenas J; Hoskin DW; McCormick JK; Haeryfar SM
Clin Exp Immunol; 2009 Jul; 157(1):60-70. PubMed ID: 19659771
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.
Kim H; Darwish I; Monroy MF; Prockop DJ; Liles WC; Kain KC
BMC Immunol; 2014 Jan; 15():1. PubMed ID: 24423010
[TBL] [Abstract][Full Text] [Related]
8. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
Rieder SA; Nagarkatti P; Nagarkatti M
Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
[TBL] [Abstract][Full Text] [Related]
9. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
[TBL] [Abstract][Full Text] [Related]
10. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
[TBL] [Abstract][Full Text] [Related]
11. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm.
Faulkner L; Cooper A; Fantino C; Altmann DM; Sriskandan S
J Immunol; 2005 Nov; 175(10):6870-7. PubMed ID: 16272345
[TBL] [Abstract][Full Text] [Related]
13. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome.
Tilahun AY; Holz M; Wu TT; David CS; Rajagopalan G
PLoS One; 2011 Feb; 6(2):e16764. PubMed ID: 21304813
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock.
Rajagopalan G; Asmann YW; Lytle AK; Tilahun AY; Theuer JE; Smart MK; Patel R; David CS
Shock; 2008 Dec; 30(6):721-8. PubMed ID: 18496243
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.
Tilahun AY; Chowdhary VR; David CS; Rajagopalan G
J Immunol; 2014 Sep; 193(6):2919-30. PubMed ID: 25092888
[TBL] [Abstract][Full Text] [Related]
16. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
Rajagopalan G; Iijima K; Singh M; Kita H; Patel R; David CS
Infect Immun; 2006 Feb; 74(2):1284-96. PubMed ID: 16428778
[TBL] [Abstract][Full Text] [Related]
17. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
Saha B; Harlan DM; Lee KP; June CH; Abe R
J Exp Med; 1996 Jun; 183(6):2675-80. PubMed ID: 8676089
[TBL] [Abstract][Full Text] [Related]
18. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
[TBL] [Abstract][Full Text] [Related]
19. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
Rajagopalan G; Smart MK; Murali N; Patel R; David CS
J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
[TBL] [Abstract][Full Text] [Related]
20. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
